RM Pharma

The medication you're asking about is a combination of empagliflozin (5mg) and metformin hydrochloride for the treatment of type 2 diabetes. It works by lowering blood sugar through two mechanisms: empagliflozin helps the body remove excess sugar through urine, and metformin decreases glucose production by the liver and improves insulin sensitivity. This medication is often used alongside diet and exercise and is prescribed to lower blood sugar and reduce the risk of cardiovascular disease in people with type 2 diabetes.  

Empafox MET is a prescription oral medication used to manage blood sugar levels in adults with type 2 diabetes. It is intended to be used along with a proper diet and exercise program. This combination medication offers a dual approach to blood glucose control: 

Empagliflozin 10mg tablets, commonly sold under brand names like Empafox, Jardiance, Gibtulio, and Empanorm, are a type of oral medication for managing blood glucose levels in adults and children aged 10 and older with type 2 diabetes. It is a potent and selective sodium-glucose co-transporter 2 (SGLT2) inhibitor, which works independently of insulin. By blocking the SGLT2 protein in the kidneys, the medication prevents the reabsorption of glucose, causing excess sugar to be flushed out of the body through urine. 

Glycifox Metformin Hydrochloride Sustained Release (SR) Tablets IP 850mg are primarily used to treat type 2 diabetes. The medication is typically prescribed when diet and exercise alone are not enough to manage blood sugar levels. 

The tablets are a combination medication for type 2 diabetes containing Dapagliflozin, Teneligliptin, and Metformin Hydrochloride Extended Release. They work together to lower blood glucose by helping the kidneys excrete more sugar, increasing insulin release, decreasing glucose production in the liver, and increasing the body's sensitivity to insulin. This combination is a treatment option to improve blood sugar control, and should be taken as prescribed by a doctor, usually with food. 

The medication Jempra-L (or similar combination brands like Gempa L, Glempa L, and Empanorm L) is a 25mg empagliflozin and 5mg linagliptin tablet used to manage type 2 diabetes by lowering blood sugar. Empagliflozin works by helping the kidneys excrete excess sugar through urine, while linagliptin increases insulin production and decreases the liver's sugar production. It is also prescribed to reduce cardiovascular death risk in adults with type 2 diabetes and heart disease.  

Based on the active ingredients empagliflozin and linagliptin, Jempra-L is a combination medicine used to treat adults with type 2 diabetes. It is prescribed along with diet and exercise to help control high blood sugar levels. 

"Janechem-M" is a brand name for a combination medication containing 500mg of Metformin Hydrochloride and 50mg of Sitagliptin Phosphate, used to treat type 2 diabetes. It works by improving blood sugar control through increased insulin production and sensitivity while decreasing the liver's glucose output. This tablet should be taken as a single dose, with meals, and as prescribed by a doctor to manage blood sugar levels alongside diet and exercise. 

"Vidaduss-M" is a combination medication containing vildagliptin and metformin hydrochloride, used to manage Type 2 diabetes by controlling blood sugar levels when diet and exercise alone are not enough. The "1050mg" in the product name likely refers to the total combined weight of the two active ingredients in a tablet. A common combination of this type is 1000mg of metformin and 50mg of vildagliptin, which adds up to 1050mg. 

A 1050mg Janechem-M tablet is a combination medication containing sitagliptin phosphate (50 mg) and metformin hydrochloride (1000 mg) and is used to treat type 2 diabetes. It works alongside a healthy diet and exercise to help adults control their blood sugar levels. 

Based on the active ingredients—Dapagliflozin, Teneligliptin, and Metformin Hydrochloride—the Tenevag tablet is a combination medicine primarily used to treat type 2 diabetes. It is typically prescribed when diet, exercise, and other diabetes medicines are not enough to control blood sugar levels. 

Based on the provided query and search results, "550mg Vidaduss-M Vildagliptin and Metformin Hydrochloride Tablets IP" is a combination medication for managing Type 2 diabetes. The total strength of 550mg corresponds to two active ingredients: 50mg of Vildagliptin and 500mg of Metformin Hydrochloride. 

500mg Imeglim tablets contain imeglimin hydrochloride, a novel oral antidiabetic agent belonging to the "glimin" class. It is prescribed for adults with type 2 diabetes mellitus to help control blood sugar levels, especially when diet and exercise alone are not enough. The medication can also be used in combination with other antidiabetic drugs.